Black Titan Corporation
BTTC evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for BTTC—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · BTTC
Black Titan Corporation (BTTC) is a Cayman Islands holding company formed to effect a merger among Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd, operating in the HCM cloud solutions space with a focus on the APAC region.
Key risk: Going concern uncertainty
Market Cap
$4.7M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Jul 31, 2025.
Black Titan Corporation (BTTC) is a Cayman Islands holding company formed to effect a merger among Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd, operating in the HCM cloud solutions space with a focus on the APAC region.
- Formed in July 2024 for the purpose of effecting a merger among Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd [sec · filed 2025-11-28].
- As of January 31, 2026, the company had cash, cash equivalents and restricted cash totaling $4,604,980 [sec · filed 2026-06-12].
- Generated a net profit of $209,911 for the year ended July 31, 2025, but incurred a net loss of $3,092,512 for the six months ended January 31, 2026 [sec · filed 2026-06-12].
- Management is developing an HCM cloud solution with a beta version scheduled for rollout in the 2026 second fiscal quarter [sec · filed 2026-06-12].
- Shareholders' equity was -$0.0M as of 2025-07-31 [sec].
What works
- The company generated a net profit of $209,911 and net cash provided by operating activities of $394,218 for the year ended July 31, 2025, indicating a period of profitability [sec · filed 2026-06-12].
- Management is developing an HCM cloud solution targeting the APAC region, capitalizing on post-pandemic economic growth and trends toward digital trade rules [sec · filed 2026-06-12].
What to weigh
- The company incurred a net loss of $3,092,512 and net cash used in operating activities of $3,966,928 for the six months ended January 31, 2026, a significant reversal from the prior year [sec · filed 2026-06-12].
- The company's financial statements have been prepared on a going concern basis, indicating uncertainty about its ability to continue as a going concern [sec · filed 2025-11-28].
- Shareholders' equity was negative at -$0.0M as of 2025-07-31 [sec].
- The company faces risks related to international operations, including higher costs, export/import regulations, and trade restrictions [sec · filed 2025-11-28].
From the filings
Quoted directly from source documents.
Cash position as of January 31, 2026
“As of January 31, 2026, we had cash, cash equivalents and restricted cash totaling $4,604,980.”
SEC filings · January 31, 2026
Net loss for six months ended January 31, 2026
“We incurred net loss of $3,092,512 and net cash used in operating activities of $3,966,928 for the six months ended Jan”
SEC filings · January 31, 2026
Going concern uncertainty
“The Company's financial statements have been prepared on a going concern basis.”
SEC filings · November 28, 2025
HCM cloud solution development
“management has embarked on a development HCM cloud solution and scheduled to roll out the beta version of the software in the 2026 second fiscal quarter.”
SEC filings · June 12, 2026
Risks & what to watch (4)›
Key risks
- Going concern uncertainty — Financial statements prepared on a going concern basis, indicating potential inability to continue operations [sec · filed 2025-11-28].
- Negative shareholders' equity — Shareholders' equity was -$0.0M as of 2025-07-31, indicating liabilities exceed assets [sec].
- Recent net loss — Net loss of $3,092,512 for six months ended January 31, 2026, after a profitable prior year [sec · filed 2026-06-12].
- International operations risks — Exposed to higher costs, export/import regulations, and trade restrictions in global markets [sec · filed 2025-11-28].
What to watch
- Rollout of beta version of HCM cloud solution in the 2026 second fiscal quarter [sec · filed 2026-06-12].
- Ability to return to profitability after the net loss in the six months ended January 31, 2026 [sec · filed 2026-06-12].
- Cash runway given cash of $4,604,980 as of January 31, 2026 and ongoing operating cash burn [sec · filed 2026-06-12].
Sources: SEC filings · Generated August 26, 2026 · How we verify sources →
Run Black Titan Corporation through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Black Titan Corporation facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$77K
| Holder | Shares | Value |
|---|---|---|
| marex group plc | 54,983 | $77K |
| group one trading llc | 12 | $17 |
| osaic holdings, inc. | 9 | $10 |
| blackrock, inc. | 6 | $8 |
| morgan stanley | 2 | $3 |
| mcguire capital advisors inc | 2 | $3 |
| us bancorp \de\ | 1 | $1 |
| pnc financial services group, inc. | 1 | $1 |
Short Interest
- % of float
- -
- Days to cover
- —
- Shares short
- -
- Daily short volume (Aug 28, 2026)
- 28.5%
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
BTTC short interestThe AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.